Financial Year |
March 31 2023 |
Monetary Funds |
10,681,709,584.42 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
278,144.44 |
Accounts Receivable |
19,603,770,071.89 |
Advances to Suppliers |
125,732,514.56 |
Other Receivables |
327,160,987.60 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
587,684,228.46 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
552,826,275.47 |
Total Current Assets |
31,879,161,806.84 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
67,950,510,377.22 |
Investment Properties |
96,657,190.57 |
Fixed Assetes |
445,664,890,267.13 |
Under-construction Projects |
3,987,617,251.27 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
21,908,758,521.20 |
R&D expenses |
90,768,249.91 |
Goodwill |
1,066,690,110.61 |
Long-Term Deferred and Prepaid Expenses |
55,533,966.62 |
Deferred Income Tax Assets |
420,783,494.25 |
Other Non-Current Assets |
245,690,763.25 |
Sub-Total of Non-Current Assets |
548,120,987,424.59 |
Total Assets |
580,000,149,231.43 |
Short-Term Loans |
71,840,853,921.67 |
Trading Financial liabilities |
-- |
Notes Payable |
1,482,159.19 |
Accounts Payable |
1,012,782,231.03 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
328,955,799.19 |
Taxes Payable |
2,235,170,858.14 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
31,542,974,063.58 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
32,258,864,464.23 |
Other Current Liabilities |
13,749,239,308.68 |
Sub-Total of Current Liabilities |
153,000,443,693.02 |
Long-term Loans |
193,406,613,751.00 |
Bonds Payable |
35,439,787,340.99 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
50,595,740.61 |
Deferred Income Tax Liabilities |
2,309,396,827.68 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
231,841,847,438.00 |
Total Liabilities |
384,842,291,131.02 |
Paid-In Capital(Or Share Stock) |
23,663,781,655.00 |
Capital Surplus |
49,069,274,456.57 |
Surplus Reserve |
24,967,736,455.15 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
85,487,999,562.55 |
Minority Stockholder's Interest |
10,379,614,196.65 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
184,778,243,903.76 |
Owner's Equity(Stockholder's Equity) |
195,157,858,100.41 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
580,000,149,231.43 |